<?xml version="1.0"?>
<rss version="2.0">
  <channel>
    <title>Nephrology News - Doctors Lounge</title>
      <link>http://www.doctorslounge.com/</link>
      <description>Medical News and Information</description>
      <pubDate>Mon, 06 Oct 2008 02:59:55 PST</pubDate>
      <language>en-us</language>
      <item>
        <title>Dialysis patients with metabolic syndrome at risk of heart disease</title>
        <link>http://www.doctorslounge.com/nephrology/news/dialysis_metabolic_syndrome.shtml</link>
        <category>Nephrology News</category>
        <description>A study of kidney dialysis patients found that nearly 70 percent had metabolic syndrome.</description>
        <pubDate>Thu, 08 Mar 2007 16:10:33 PST</pubDate>
        <guid isPermaLink="true">http://www.doctorslounge.com/nephrology/news/dialysis_metabolic_syndrome.shtml</guid>
      </item>
      <item>
        <title>Fosrenol show long term benefit in chronic kidney disease</title>
        <link>http://www.doctorslounge.com/nephrology/news/ckd_fosrenol.shtml</link>
        <category>Nephrology News</category>
        <description>Additional study shows majority of patients achieve phosphorus control with reformulated Fosrenol as monotherapy.</description>
        <pubDate>Sat, 18 Nov 2006 16:09:13 PST</pubDate>
        <guid isPermaLink="true">http://www.doctorslounge.com/nephrology/news/ckd_fosrenol.shtml</guid>
      </item>
      <item>
        <title>Fosrenol does not cause cognitive dysfunction in renal disease</title>
        <link>http://www.doctorslounge.com/nephrology/news/fosrenol_cognitive_dysfunction.shtml</link>
        <category>Nephrology News</category>
        <description>Deterioration in cognitive function was found to be independent of phosphate-binder therapy, Fosrenol.</description>
        <pubDate>Wed, 18 Oct 2006 15:39:29 PST</pubDate>
        <guid isPermaLink="true">http://www.doctorslounge.com/nephrology/news/fosrenol_cognitive_dysfunction.shtml</guid>
      </item>


  </channel>
</rss>